<h2 id="id-2022103DGABMeetingnotes-Date">
  Date
</h2>
03 Oct 2022
<h2 id="id-2022103DGABMeetingnotes-Attendees">
  Attendees
</h2>
<table>
  <colgroup>
    <col/>
    <col/>
    <col/>
  </colgroup>
  <tbody>
    <tr>
      <th>
        Committee Member
      </th>
      <th>
        Present
      </th>
      <th>
        Absent
      </th>
    </tr>
    <tr>
      <td>
        <a href="https://wiki.nci.nih.gov/display/~kuffelgr" rel="nofollow">
          Kuffel, Gina (NIH/NCI) [C]
        </a>
      </td>
      <td>
        X
      </td>
      <td></td>
    </tr>
    <tr>
      <td>
        <a href="https://wiki.nci.nih.gov/display/~muskp2" rel="nofollow">
          Musk, Philip (NIH/NCI) [C]
        </a>
      </td>
      <td>
        X
      </td>
      <td></td>
    </tr>
    <tr>
      <td>
        Warren Kibbe
      </td>
      <td>
        X
      </td>
      <td></td>
    </tr>
    <tr>
      <td>
        <a href="https://wiki.nci.nih.gov/display/~kwone" rel="nofollow">
          Kim, Erika (NIH/NCI) [E]
        </a>
      </td>
      <td>
        X
      </td>
      <td></td>
    </tr>
    <tr>
      <td>
        Gregory Tawa
      </td>
      <td>
        X
      </td>
      <td></td>
    </tr>
    <tr>
      <td>
        William Hendriks
      </td>
      <td></td>
      <td>
        X
      </td>
    </tr>
    <tr>
      <td>
        Matthew Breen
      </td>
      <td></td>
      <td>
        X
      </td>
    </tr>
    <tr>
      <td>
        Roel Verhaak
      </td>
      <td>
        X
      </td>
      <td></td>
    </tr>
  </tbody>
</table>
Goals
<ul>
  <li>
    Review, discuss, and prioritize ICDC study submission proposals
  </li>
</ul>
<h2 id="id-2022103DGABMeetingnotes-OutstandingActionitems">
  Outstanding Action items
</h2>
<ul>
  <li>
    Matthew &amp; Warren to write an email request to Toby pertaining to formalization of a business plan for ICDC.
  </li>
  <li>
    <a href="https://wiki.nci.nih.gov/display/~muskp2" rel="nofollow">
      Musk, Philip (NIH/NCI) [C]
    </a>
    to brush up on Nanostring documentation.
  </li>
</ul>
<h2 id="id-2022103DGABMeetingnotes-Agenda">
  Agenda
</h2>
<table>
  <colgroup>
    <col/>
    <col/>
    <col/>
  </colgroup>
  <tbody>
    <tr>
      <th>
        Discussion Item
      </th>
      <th>
        Who
      </th>
      <th>
        Notes
      </th>
    </tr>
    <tr>
      <td>
        New data submission request
      </td>
      <td>
        <a href="https://wiki.nci.nih.gov/display/~kuffelgr" rel="nofollow">
          Kuffel, Gina (NIH/NCI) [C]
        </a>
      </td>
      <td>
        <ul>
          <li>
            Email Q&amp;A with submitter
          </li>
          <li>
            Data Submission Folder:
            <a href="https://nih.sharepoint.com/:f:/r/sites/NCI-CBIIT-FNL-ICDC-ICDCLeadershipGroups/Shared%20Documents/ICDC%20Leadership%20Groups/ICDC%20Steering%20Committee/DGAB/Data%20Submissions/Incoming/Tissues%20%26%20Organoids?csf=1&amp;web=1&amp;e=HBS7g7" rel="nofollow">
              Tissues &amp; Organoids
            </a>
          </li>
          <li>
            <a href="https://nih.sharepoint.com/:x:/r/sites/NCI-CBIIT-FNL-ICDC-ICDCLeadershipGroups/Shared%20Documents/ICDC%20Leadership%20Groups/ICDC%20Data%20Dashboard.xlsx?d=w828279c821a349b9b4c1cef44e5c3743&amp;csf=1&amp;web=1&amp;e=BtxsQ3" rel="nofollow">
              ICDC Data Dashboard.xlsx
            </a>
          </li>
        </ul>
      </td>
    </tr>
    <tr>
      <td>
        Data submission approved by Senior Advisory Committee
      </td>
      <td>
        <a href="https://wiki.nci.nih.gov/display/~kuffelgr" rel="nofollow">
          Kuffel, Gina (NIH/NCI) [C]
        </a>
      </td>
      <td>
        <ul>
          <li>
            &#34;Immune Pathways and TP53 missense mutations are associated with longer survival in canine osteosarcoma&#34;
          </li>
          <li>
            Data Submission Folder:
            <a href="https://nih.sharepoint.com/:f:/r/sites/NCI-CBIIT-FNL-ICDC-ICDCLeadershipGroups/Shared%20Documents/ICDC%20Leadership%20Groups/ICDC%20Steering%20Committee/DGAB/Data%20Submissions/Incoming/OSA-Normal?csf=1&amp;web=1&amp;e=ofBsVu" rel="nofollow">
              OSA-Normal
            </a>
          </li>
          <li>
            Onboarding meeting set up with submitters
          </li>
          <li>
            Study will be called OSA02
          </li>
        </ul>
      </td>
    </tr>
    <tr>
      <td>
        PRECINCT Data Request Submission: Inhaled IL-15 Immunotherapy for Treatment of Lung Metastases
      </td>
      <td>
        All
      </td>
      <td>
        <ul>
          <li>
            <a href="https://nih.sharepoint.com/:f:/r/sites/NCI-CBIIT-FNL-ICDC-ICDCLeadershipGroups/Shared%20Documents/ICDC%20Leadership%20Groups/ICDC%20Steering%20Committee/DGAB/Data%20Submissions/Incoming/PRECINCT?csf=1&amp;web=1&amp;e=TbYcgE" rel="nofollow">
              PRECINCT
            </a>
            SharePoint submission folder
          </li>
          <li>
            <a href="https://jitc.bmj.com/content/10/6/e004493" rel="nofollow">
              PRECINCT Publication
            </a>
          </li>
          <li>
            Recently met with UC Davis team to demo the ICDC and discuss next steps for ingesting additional data.
          </li>
        </ul>
      </td>
    </tr>
    <tr>
      <td>
        Review of other Modiano publications:
        <a href="https://gcc02.safelinks.protection.outlook.com/ap/x-59584e83/?url=https%3A%2F%2Fnih.sharepoint.com%2F%3Ax%3A%2Fr%2Fsites%2FNCI-CBIIT-FNL-ICDC-ICDCLeadershipGroups%2FShared%2520Documents%2FICDC%2520Leadership%2520Groups%2FICDC%2520Steering%2520Committee%2FDGAB%2FData%2520Submissions%2FIncoming%2FCandidate%2520Publication%2520Test%2520Case%2FOther%2520Modiano%2520Publication%2520Considerations.xlsx%3Fd%3Dwa54b0b0460de4a899cdf33954e76e44f%26csf%3D1%26web%3D1%26e%3D7xkrPj&amp;data=05%7C01%7Cgina.kuffel%40nih.gov%7C614d699100c14a97c2bc08da351a71f6%7C14b77578977342d58507251ca2dc2b06%7C0%7C0%7C637880685084301351%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C3000%7C%7C%7C&amp;sdata=nTjrlntlTBy6NuhZ4vYgds6TFcL9GgL6b5a82Zku0gI%3D&amp;reserved=0" rel="nofollow">
          Other Modiano Publication Considerations.xlsx
        </a>
      </td>
      <td>
        <a href="https://wiki.nci.nih.gov/display/~kuffelgr" rel="nofollow">
          Kuffel, Gina (NIH/NCI) [C]
        </a>
      </td>
      <td>
        <ul>
          <li>
            <a href="https://pubmed.ncbi.nlm.nih.gov/33127576/" rel="nofollow">
              Modiano Osteosarcoma paper
            </a>
            approved by SAC on 4/19/21
          </li>
          <li>
            <a href="https://nih.sharepoint.com/:x:/r/sites/NCI-CBIIT-FNL-ICDC-ICDCLeadershipGroups/Shared%20Documents/ICDC%20Leadership%20Groups/ICDC%20Steering%20Committee/DGAB/Data%20Submissions/Incoming/Candidate%20Publication%20Test%20Case/Canine_clinical_ICDC_GSE149679.csv?d=w090255a420a1492a8fad7abdfa8f5442&amp;csf=1&amp;web=1&amp;e=dtCnbN" rel="nofollow">
              Clinical data
            </a>
            received on 3/17/22
          </li>
          <li>
            <a href="https://nih.sharepoint.com/:w:/r/sites/NCI-CBIIT-FNL-ICDC-ICDCLeadershipGroups/Shared%20Documents/ICDC%20Leadership%20Groups/ICDC%20Steering%20Committee/DGAB/Data%20Submissions/Incoming/Candidate%20Publication%20Test%20Case/Other%20Datasets.docx?d=w354a3047ffbf49d5a7c3e516755cf1f3&amp;csf=1&amp;web=1&amp;e=2ehgpE" rel="nofollow">
              Other Modiano publications for consideration
            </a>
          </li>
        </ul>
      </td>
    </tr>
    <tr>
      <td>
        Study Updates
      </td>
      <td>
        <a href="https://wiki.nci.nih.gov/display/~muskp2" rel="nofollow">
          Musk, Philip (NIH/NCI) [C]
        </a>
      </td>
      <td>
        <ul>
          <li>
            TCL01
            <ul>
              <li>
                Study identifier changed to TCL01 (Tumor Cell Line)
              </li>
              <li>
                Testing completed
              </li>
              <li>
                Pending release record available on production
              </li>
              <li>
                Still waiting on 6 study files
              </li>
            </ul>
          </li>
          <li>
            PRECINCT
            <ul>
              <li>
                Program now available on lower tier (dev environment)
              </li>
              <li>
                Study record is in place
              </li>
              <li>
                Working on Adverse Event node
              </li>
              <li>
                Need follow-up call
              </li>
            </ul>
          </li>
          <li>
            PANCAN01 (15 TB Re-analysis)
            <ul>
              <li>
                Data is already in a ICDC S3 bucket
              </li>
              <li>
                Template-driven study onboarding initiated
              </li>
              <li>
                One study will be onboarded at a time
              </li>
              <li>
                Need to determine which study will be ingested first
              </li>
            </ul>
          </li>
          <li>
            OSA02
            <ul>
              <li>
                Onboarding meeting scheduled for Thursday
              </li>
            </ul>
          </li>
        </ul>
      </td>
    </tr>
  </tbody>
</table>
<h2 id="id-2022103DGABMeetingnotes-Minutes(NotVerbatim)">
  Minutes (Not Verbatim)
</h2>
**Discussion of Q&amp;A email thread with data submitters of Tissue &amp; Organoid study**GT- Some science associated with cancer and IBD, evident link but not an expert in this area.PM - The submission seems to be more about IBD than it is about cancer based on our discussionRV - Is this a good fit for our data repo? Would sending it away prevent this data from ever being made accessible to the public?RV - How many of the patient samples will ultimately have omics data associated with them?WK - Struggling with the strong rationale to import this data. EK - Need metadata for the cancer related samples.WK - Is there a place where these organoids can be validated and made available for other researchers?GT - There are members of the SC that can help with depositing samples to and getting samples from, Christine Mazcko is our contact.RV - The submission is beyond the scope of our resource, however we should help to make this data available.GT - What is their plan is to have genomic coverage for all individuals?WK - In favor of finding a way to accept.EK - Potentially leverage resources from DCTD, looks like their grant involves drug development for bladder cancer.WK - Moving into the drug screening space would be valuable.
<h2 id="id-2022103DGABMeetingnotes-Actionitems">
  Action items
</h2>
<ul>
  <li>
    Greg to reach out to Christine Mazcko about potential biobanking resources for the organoids
  </li>
  <li>
    <a href="https://wiki.nci.nih.gov/display/~kwone" rel="nofollow">
      Kim, Erika (NIH/NCI) [E]
    </a>
    will reach out to DCTD for patient derived repository to determine if canines are included:
    <a href="https://pdmr.cancer.gov/database/default.htm" rel="nofollow">
      https://pdmr.cancer.gov/database/default.htm
    </a>
  </li>
  <li>
    <a href="https://wiki.nci.nih.gov/display/~kuffelgr" rel="nofollow">
      Kuffel, Gina (NIH/NCI) [C]
    </a>
    to send email summarizing plan to data submitter
  </li>
</ul>